drugset / Trial / NCT01600105

Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)

NCT01600105

Phase 4 Completed 276 enrolled Bachir Taouli
NaSingle-groupOpen-labelDiagnostic

Summary

Patients with chronic liver disease are at high risk of developing liver scarring (fibrosis), with ultimate risks of cirrhosis and liver cancer that may require liver transplant. The investigators would like to develop non invasive advanced Magnetic Resonance Imaging (MRI) techniques (MR diffusion, perfusion and elastography) to assess the degree of liver damage in patients with chronic liver disease. These techniques combined could reach high diagnostic performance for detection of liver fibrosis; and could decrease the number of liver biopsies, which have risks and sample only a small portion of the liver.

Timeline

Start
2010-10
Primary completion
2017-07-31
Completion
2017-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadofosveset Diagnostic / imaging agent

Indications